Update on the Treatment of Diabetic Retinopathy
Retinopathy is the most feared complication of diabetes, compromising quality of life in most sufferers. Almost all patients with type 1 diabetes will develop retinopathy over a 15- to 20-year period, and approximately 20–30% will advance to the blinding stage of the disease[1]. Greater than 60% of...
Saved in:
Main Authors: | Jennifer L. Wilkinson-Berka, Antonia G. Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2008-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2008.25 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of SGLT2 Inhibitor on the Treatment of Diabetic Retinopathy
by: Wenjun Sha, et al.
Published: (2020-01-01) -
Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy
by: Lorena Perrone, et al.
Published: (2014-01-01) -
The Adenosinergic System in Diabetic Retinopathy
by: J. Vindeirinho, et al.
Published: (2016-01-01) -
The Vitreomacular Interface in Diabetic Retinopathy
by: Daniel Agarwal, et al.
Published: (2015-01-01) -
Erratum to “Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy”
by: Lorena Perrone, et al.
Published: (2014-01-01)